Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease
Sickle cell disease (SCD) is the most common inherited disease. Pain is a key morbidity of SCD and opioids are the main treatment but their side effects emphasize the need for new analgesic approaches. Humanized transgenic mouse models have been instructive in understanding the pathobiology of SCD...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ferrata Storti Foundation
2022-05-01
|
| Serija: | Haematologica |
| Online pristup: | https://haematologica.org/article/view/10659 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|